Innovation

11 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 244 times.

Year	Filings
2012	2
2013	7
2014	7

Investor mix

6 investors on record; lead investors include CMEA Capital, Sofinnova Investments, Novartis.

Investor type	Count	Share
Venture capital	4	67%
Other / undisclosed	2	33%